Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenue	$ 166		$ 612	$ 189
Operating expenses:
Cost of revenue	1,685	0	3,030	369
Sales and marketing	4,339	4,898	8,877	8,823
General and administrative	6,652	11,196	16,670	20,672
Amortization of acquired intangible assets	505	650	1,010	773
Research and development	3,469	6,740	7,909	12,671
Total operating expenses	16,650	23,484	37,496	43,308
Operating loss	(16,484)	(23,484)	(36,884)	(43,119)
Other income (expense):
Interest income	163	7	283	9
Interest expense	(228)	(523)	(411)	(523)
Change in fair value - Senior Secured Convertible Notes	(340)	(2,000)	(1,380)	(2,000)
Loss on issue and offering costs - Senior Secured Convertible Note		(3,101)	(1,186)	(3,101)
Debt extinguishments loss - Senior Secured Convertible Notes	(743)		(1,268)
Change in fair value - derivative liability	(260)		(260)
Gain on sale of intellectual property			1,000
Other income (expense), net	(1,408)	(5,617)	(3,222)	(5,615)
Loss before provision for income tax	(17,892)	(29,101)	(40,106)	(48,734)
Provision for income taxes
Net loss before noncontrolling interests	(17,892)	(29,101)	(40,106)	(48,734)
Net loss attributable to the noncontrolling interests	3,355	3,576	7,638	6,337
Net loss attributable to PAVmed Inc.	(14,537)	(25,525)	(32,468)	(42,397)
Less: Series B Convertible Preferred Stock dividends earned	(75)	(70)	(149)	(138)
Net loss attributable to PAVmed Inc. common stockholders	$ (14,612)	$ (25,595)	$ (32,617)	$ (42,535)
Per share information:
Net loss per share attributable to PAVmed Inc. - basic	$ (0.14)	$ (0.29)	$ (0.32)	$ (0.49)
Net loss per share attributable to PAVmed Inc. - diluted	(0.14)	(0.29)	(0.32)	(0.49)
Net loss per share attributable to PAVmed Inc. common stockholders - basic	(0.14)	(0.29)	(0.32)	(0.49)
Net loss per share attributable to PAVmed Inc. common stockholders - diluted	$ (0.14)	$ (0.29)	$ (0.32)	$ (0.49)
Weighted average common shares outstanding, basic	104,349,822	86,957,352	100,742,530	86,689,857
Weighted average common shares outstanding, diluted	104,349,822	86,957,352	100,742,530	86,689,857